UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease

Condition:   COVID-19 Infection Intervention:   Drug: ursodeoxycholic acid Sponsor:   Beijing Ditan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials